Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR

Author:

Sureda Anna1ORCID,Zhang Mei-Jie23,Dreger Peter4,Carreras Jeanette2,Fenske Timothy5,Finel Herve6,Schouten Harry7,Montoto Silvia8,Robinson Stephen9,Smith Sonali M.10,Boumedil Ariane6,Hamadani Mehdi2ORCID,Pasquini Marcelo C.2

Affiliation:

1. Hematology Department; Institut Català d'Oncologia-Hospitalet; Barcelona Spain

2. Center for International Blood and Marrow Transplant Research, Department of Medicine; Medical College of Wisconsin; Milwaukee Wisconsin

3. Division of Biostatistics, Institute for Health and Society; Medical College of Wisconsin; Milwaukee Wisconsin

4. Universitaetsklinkum Heidelberg; Heidelberg Germany

5. Division of Hematology and Oncology, Department of Medicine; Medical College of Wisconsin; Milwaukee Wisconsin

6. Central Registry Office; European Society for Blood and Marrow Transplantation; Paris France

7. Department of Hematology; Academische Ziekenhuis; Maastricht the Netherlands

8. Department of Haemato-Oncology, St. Bartholomew's Hospital; Barts Health NHS Trust; London United Kingdom

9. University Hospitals Bristol NHS Trust; Bristol United Kingdom

10. Section of Hematology/Oncology; University of Chicago; Chicago Illinois

Funder

National Cancer Institute

National Heart, Lung, and Blood Institute

National Institute of Allergy and Infectious Diseases

the National Cancer Institute and the National Heart, Lung, and Blood Institute

Health Resources and Services Administration

Office of Naval Research

Actinium Pharmaceuticals, Inc

Alexion

Amgen, Inc

Astellas Pharma US

AstraZeneca

Atara Biotherapeutics, Inc

Be the Match Foundation

Bluebird Bio, Inc

Bristol-Myers Squibb Oncology

Celgene Corporation

Cellular Dynamics International, Inc

Cerus Corporation

Chimerix, Inc

Fred Hutchinson Cancer Research Center

Gamida Cell, Ltd

Genentech, Inc

Genzyme Corporation

Gilead Sciences, Inc

Health Research, Inc

Roswell Park Cancer Institute

HistoGenetics, Inc

Incyte Corporation

Janssen Scientific Affairs, LLC

Jazz Pharmaceuticals, Inc

the Jeff Gordon Children's Foundation

the Leukemia & Lymphoma Society

Medac, GmbH; MedImmune

Medical College of Wisconsin

Merck & Co, Inc

Mesoblast

MesoScale Diagnostics, Inc

Miltenyi Biotec, Inc

the National Marrow Donor Program

Neovii Biotech NA, Inc

Novartis Pharmaceuticals Corporation

Onyx Pharmaceuticals

Optum Healthcare Solutions, Inc

Otsuka America Pharmaceutical, Inc

Otsuka Pharmaceutical Co, Ltd (Japan)

the Patient-Centered Outcomes Research Institute

PerkinElmer, Inc

Pfizer, Inc

Sanofi US

Seattle Genetics

Spectrum Pharmaceuticals, Inc

St. Baldrick's Foundation

Sunesis Pharmaceuticals, Inc

Swedish Orphan Biovitrum, Inc

Takeda Oncology

Telomere Diagnostics, Inc

University of Minnesota

WellPoint, Inc

Publisher

Wiley

Subject

Cancer Research,Oncology

Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3